Clinical trials
Phase 1/2 Blood Protein Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 2 |
| 2011 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2022 | 2 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2 |
| Recruiting | 2 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hellenic Society of Hematology | 3 |
| ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 1 |
| Astex Pharmaceuticals, Inc. | 1 |
| Celgene | 1 |
| Kyowa Kirin Co., Ltd. | 1 |
| Senesco Technologies, Inc. | 1 |
| Shenzhen University General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Blood Protein Disorders | 9 |
| Neoplasms, Plasma Cell | 9 |
| Hematologic Diseases | 8 |
| Multiple Myeloma | 8 |
| Neoplasms | 7 |
| Paraproteinemias | 7 |
| Immune System Diseases | 4 |
| Immunoproliferative Disorders | 4 |
| Neoplasms by Histologic Type | 4 |
| Corneal Diseases | 3 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.